相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。BikDD Eliminates Breast Cancer Initiating Cells and Synergizes with Lapatinib for Breast Cancer Treatment
Jing-Yu Lang et al.
CANCER CELL (2011)
Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways
Siyuan Zhang et al.
NATURE MEDICINE (2011)
Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition
B. N. Rexer et al.
ONCOGENE (2011)
Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase
Joan T. Garrett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
X-Linked Inhibitor of Apoptosis Protein Inhibits Apoptosis in Inflammatory Breast Cancer Cells with Acquired Resistance to an ErbB1/2 Tyrosine Kinase Inhibitor
Katherine M. Aird et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Regulation of XIAP Translation and Induction by MDM2 following Irradiation
Lubing Gu et al.
CANCER CELL (2009)
Overcoming resistance to tyrosine kinase inhibitors Lessons learned from cancer cells treated with EGFR antagonists
Brent N. Rexer et al.
CELL CYCLE (2009)
Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression
Samuel Godar et al.
CELL (2008)
Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapy
Stephen Johnston et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Inhibition of apoptosome formation by suppression of Hsp90β phosphorylation in tyrosine kinase-induced leukemias
Manabu Kurokawa et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
PHAPI, CAS, and Hsp70 promote apoptosome formation by preventing Apaf-1 aggregation and enhancing nucleotide exchange on Apaf-1
Hyun-Eui Kim et al.
MOLECULAR CELL (2008)
Lapatinib resistance in HCT116 cells is mediated by elevated MCL-1 expression and decreased BAK activation and not by ERBB receptor kinase mutation
Aditi Pandya Martin et al.
MOLECULAR PHARMACOLOGY (2008)
The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein
Xudong Zhao et al.
NATURE CELL BIOLOGY (2008)
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
Sanjeev Shangary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cdc6 stability is regulated by the Huwe1 ubiquitin ligase after DNA damage
Jonathan R. Hall et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes
Tomoaki Tanaka et al.
CELL (2007)
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype:: Lessons from recent developments in the IARC TP53 database
Audrey Petitjean et al.
HUMAN MUTATION (2007)
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Jeffrey A. Engelman et al.
SCIENCE (2007)
Small molecule HER-2 tyrosine kinase inhibitors
Neil Spector et al.
BREAST CANCER RESEARCH (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
A model of acquired autoresistance to a potent ErbB2 tyrosine kinase inhibitor and a therapeutic strategy to prevent its onset in breast cancer
Wenle Xia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The phosphatase Ppt1 is a dedicated regulator of the molecular chaperone Hsp90
SK Wandinger et al.
EMBO JOURNAL (2006)
The ubiquitin ligase HectH9 regulates transcriptional activation by myc and is essential for tumor cell proliferation
S Adhikary et al.
CELL (2005)
Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis
Q Zhong et al.
CELL (2005)
ARF-BP1/mule is a critical mediator of the ARF tumor suppressor
DL Chen et al.
CELL (2005)
Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: Implications for Lewy body formation
KL Lim et al.
JOURNAL OF NEUROSCIENCE (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Mutational spectrum of p53 mutations in primary breast and ovarian tumors
A Feki et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
ME Gorre et al.
SCIENCE (2001)
Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53
SY Fang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
